Blood Stem Cell Transplant Could Reboot Immune System in Multiple Sclerosis Patients - Neuroscience News

Summary: 80% of patients with multiple sclerosis remain disease-free for the long term following an autologous hematopoietic stem cell transplant. Every day, one person in Switzerland is diagnosed with multiple sclerosis. MS is an autoimmune disease in which the body's own immune system attacks the myelin sheath of the nerve cells in the brain and spinal cord. The disease leads to paralysis, pain and permanent fatigue, among other symptoms. Fortunately, there have been great advances in therapies in recent decades.